After discontinuing danuglipron (PF-06882961) due to tolerability, Pfizer is advancing conveglipron (PF-08653944) in Phase 3 for obesity + T2D
Understanding Semaglutide & Tirzepatide in simple terms How the GLP-1 wellness industry works Different business models and revenue streams How to partner with telehealth providers and pharmacies Client onboarding systems and workflows Compliance, legal considerations, and risk management Pricing strategies and profitable service packages CRM systems and business automation Marketing and lead generation strategies Sales techniques that convert consultations into clients Client retention and recurring revenue strategies Business operations and scaling for long-term success Real-world business trainingnot just theory Proven business systems and implementation strategies Marketing resources and client acquisition tools CRM and automation guidance Live instructor-led training with interactive Q&A Business documents, templates, and operational resources Lifetime access to the DMW Academy Student Portal Certificate of Completion Important Licensing Information The DMW GLP-1 Business Accelerator Course is a business and operational training program
the 60-capsule format corresponds exactly to a 2-month course
The convenient dropper allows precise dosing -take directly, sublingually, or mix into water or juice for flexible daily use
We want patients to have access to this medication. Recently, the FDA announced the removal of certain compounded GLP-1 ingredients from its drug shortage list
Hippocampus 25 , 13801392 (2015)
